Organon Arixtra Anti-Thrombotic Could Clear FDA By Mid-August
Executive Summary
Organon's anti-thrombotic agent Arixtra could receive approval from FDA in mid-August, Organon President Hans Vemer told the Goldman Sachs healthcare conference June 12 in Dana Point, Calif.